The estimated Net Worth of William G Dempsey is at least $52.4 Million dollars as of 7 August 2007. Mr. Dempsey owns over 124,436 units of Hill-Rom Inc stock worth over $50,093,728 and over the last 21 years he sold HRC stock worth over $1,878,105. In addition, he makes $382,148 as Non-Executive Independent Chairman of the Board at Hill-Rom Inc.
Sign up
Mr. Dempsey HRC stock SEC Form 4 insiders trading
William has made over 15 trades of the Hill-Rom Inc stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 124,436 units of HRC stock worth $5,262,398 on 7 August 2007.
The largest trade he's ever made was exercising 124,436 units of Hill-Rom Inc stock on 7 August 2007 worth over $5,262,398. On average, William trades about 10,569 units every 29 days since 2003. As of 7 August 2007 he still owns at least 321,196 units of Hill-Rom Inc stock.
You can see the complete history of Mr. Dempsey stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Dempsey biography
William G. Dempsey serves as Non-Executive Independent Chairman of the Board of the Company. Mr. Dempsey previously held various executive positions with Abbott Laboratories from 1982 until 2007, including Executive Vice President of Global Pharmaceuticals from 2006, Senior Vice President of Pharmaceutical Operations from 2003 and Senior Vice President of International Operations from 1999. He currently serves as a director of Ashland, Inc. (where he serves on the audit, and governance and nominating committees), and was previously on the boards of Nordion, Inc. through 2014, Hospira, Inc., through 2015 and Landauer Inc., through 2017. He has previously served as a member of the Salvation Army Advisory Board in Chicago, as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative (a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies). He is a member of the Board of Trustees for the Guadalupe Center in Immokalee, Florida.
What is the salary of William Dempsey?
As the Non-Executive Independent Chairman of the Board of Hill-Rom Inc, the total compensation of William Dempsey at Hill-Rom Inc is $382,148. There are 9 executives at Hill-Rom Inc getting paid more, with John Groetelaars having the highest compensation of $7,326,160.
How old is William Dempsey?
William Dempsey is 68, he's been the Non-Executive Independent Chairman of the Board of Hill-Rom Inc since 2018. There are 1 older and 25 younger executives at Hill-Rom Inc. The oldest executive at Hill-Rom Holdings Inc is William Kucheman, 70, who is the Independent Director.
What's William Dempsey's mailing address?
William's mailing address filed with the SEC is 8145 BLAZER DRIVE, , WILMINGTON, DE, 19808.
Insiders trading at Hill-Rom Inc
Over the last 17 years, insiders at Hill-Rom Inc have traded over $30,589,508 worth of Hill-Rom Inc stock and bought 112,784 units worth $2,597,878 . The most active insiders traders include John J Greisch, W August Hillenbrand, and James R Giertz. On average, Hill-Rom Inc executives and independent directors trade stock every 20 days with the average trade being worth of $1,650,525. The most recent stock trade was executed by Andreas G Frank on 6 December 2021, trading 361 units of HRC stock currently worth $56,302.
What does Hill-Rom Inc do?
Hillrom Holdings Inc. is a global medical technology leader whose 10,000 employees have a single purpose: enhancing outcomes for patients and their caregivers by Advancing Connected Care™. Around the world, its innovations touch over 7 million patients each day. They help enable earlier diagnosis and treatment, optimize surgical efficiency and accelerate patient recovery while simplifying clinical communication and shifting care closer to home. The company makes these outcomes possible through connected smart beds, patient lifts, patient assessment and monitoring technologies, caregiver collaboration tools, respiratory health devices, advanced operating room equipment and more, delivering actionable, real-time insights at the point of care.
What does Hill-Rom Inc's logo look like?
Complete history of Mr. Dempsey stock trades at Abbott Laboratories, Ashland Inc, and Hill-Rom Inc
Hill-Rom Inc executives and stock owners
Hill-Rom Inc executives and other stock owners filed with the SEC include:
-
John Groetelaars,
President, Chief Executive Officer, Director -
Barbara Bodem,
Chief Financial Officer, Senior Vice President -
John P. Groetelaars,
Pres, CEO & Director -
Paul Johnson,
Senior Vice President, President of Patient Support Systems -
Andreas Frank,
Senior Vice President, President - Front Line Care Business -
Deborah Rasin,
Senior Vice President, Chief Legal Officer, Secretary -
Andreas G. Frank,
Sr. VP & Pres of Front Line Care business -
Barbara W. Bodem,
Sr. VP & CFO -
Paul S. Johnson,
Sr. VP & Pres of Patient Support Systems -
William Dempsey,
Non-Executive Independent Chairman of the Board -
Nancy Schlichting,
Independent Director -
Gary Ellis,
Independent Director -
Ronald Malone,
Independent Director -
James Giertz,
Independent Director -
William Kucheman,
Independent Director -
Mary Garrett,
Independent Director -
Stacy Seng,
Independent Director -
Gregory Moore,
Independent Director -
Ilana Shulman,
Chief Compliance Officer -
Anjana Harve,
Chief Information Officer -
Richard Wagner,
Chief Accounting Officer, Vice President, Controller -
Timothy Lawrence,
Senior Vice President - Operations -
Mary Ladone,
Senior Vice President - Corporate Development, Strategy and Investor Relations -
Brian Lawrence,
Chief Technology Officer -
Kenneth Meyers,
Chief Human Resource Officer, Senior Vice President -
Mary Kay Ladone,
Sr. VP of Corp. Devel., Strategy & Investor Relations -
Sue-Jean Lin,
Chief Information Officer & Sr. VP -
Brian Lawrence,
CTO & Sr. VP -
Richard M. Wagner,
VP, Controller & CAO -
Timothy P. Lawrence,
Sr. VP of Operations -
Dirk H Ehlers,
SVP President Surg Solutions -
Rolf A Classon,
Director -
Carlyn D Solomon,
Chief Operating Officer -
Eduardo S Menasce,
Director -
Kimberly K Ryan,
Group VP, N.A. Post Acute Care -
Perry Iii Stuckey,
Sr. VP and Chief HR Officer -
Gregory N Miller,
Senior VP & CFO -
Mark David Baron,
Sr. VP, Ops & Prod. Dev. -
Steven J Strobel,
Senior Vice President and CFO -
John J Greisch,
President and CEO -
Alton Shader,
Sr VP & Pres Post Acute Care -
Carlos Alonso Marum,
SVP, President International -
Jason Richardson,
VP, Controller & CAO -
Vega Francisco Canal,
SVP & Pres, Surgical Solutions -
Charles E Golden,
Director -
Gregory John Tucholski,
President, Int'l. & Surgical -
Peter H Soderberg,
President & CEO -
Maynadier Patrick D De,
Sr. VP, Gen. Counsel & Sec -
Sheri H. Edison,
Sr. VP & Chief Admin. Officer -
Chaofu Jeffrey Kao,
President, N.A. Acute Care -
Patrick T Ryan,
Director -
John H Dickey,
Vice President, Human Resource -
Kenneth A Camp,
Senior Vice President -
Rayj Hillenbrand,
Director -
Carli Earl Vincent De,
Group VP, Care Continuum Svc -
Susan R Lichtenstein,
Sr. VP & Chief Counsel -
Taylor Smith,
SVP & Pres Surg. Resp. -
Richard G Keller,
VP, Controller & CAO -
Scott R. Jeffers,
Sr. VP, Global Supply Chain -
Alejandro Infante Saracho,
President, International -
Michael Murphy,
Senior VP QA/RA -
Michael S. Macek,
VP, Treasurer and Interim CFO -
Michiel De Zwaan,
Senior VP Chief HR Officer -
W August Hillenbrand,
Director -
Michael O Oliver,
Senior VP Chief HR Officer -
Joanne C Dr Smith,
Director -
Mark Guinan,
Sr. VP and CFO -
Philip David Settimi,
Sr VP, Global Mktg & Corp. Str -
Martha Goldberg Aronson,
Sr. VP & Pres. N. America -
Edward Gregory Pritchard,
SVP & Pres Surg. Resp. -
Katherine S Zanotti,
Director -
Amy M. Dodrill,
President - Surgical Solutions -
Felicia F Norwood,